Radiolabeled 18F-fluoride PET/CT proved superior at detecting bone metastases (BM) than a comparative radiotracer, according to a Jan. 14 study published in Clinical Radiology.

"The implication is that this [change in gray matter] is potentially a consequence of cannabis use. You're changing your brain with just one or two joints. Most people would likely assume that one or two joints would have no impact on the brain," said Hugh Garavan, PhD, senior author of the study and professor of psychiatry at the University of Vermont.

The RAPID neuroimaging platform has been cleared by the FDA to use in selecting stroke patients for endovascular thrombectomy. It becomes the first imaging platform to receive such clearance for clot removal procedure, reported the creator of the technology, iSchemaView.

Spectral CT with iodine mapping helps differentiate benign pleural metastatic tumors from cancerous lesions, reported authors of a Radiology study. The iodine overlays particularly helped less-experienced radiologists.

For early-stage kidney cancer patients who may be at risk for worsening kidney disease, personalized treatment plans such as undergoing active surveillance and MRI examinations may extend life expectancy, according to new research published Jan. 15 in Radiology.

ROCHESTER, N.Y., Jan. 15 — Carestream Health was awarded 42 new patents from the U.S. Patent and Trademark Office last year for innovation in digital radiography, extremity CT imaging and other healthcare technology areas. The company also received 37 additional patents in European and Asian countries last year.

On Jan. 1, U.S. hospitals began posting prices online for all services offered, including medical imaging, in compliance with a new Trump administration order intended to increase transparency for health care consumers. However, according to a recent article from The New York Times, the policy change is "turning into a fiasco.”

Compared to microwave ablation (MWA), radiofrequency ablation (RFA) achieved better overall survival rates (OS) in lung cancer patients, according to a recent study conducted in China. Both were found to be effective and safe treatment methods.

The University of Nebraska–Lincoln was awarded $11 million from the U.S. Department of Defense to develop drug therapies that will treat radiation exposure for the military. If successful, the findings may also be applied to decreasing radiation exposure emitted from medical imaging technologies such as CT or x-rays, according to a recent report by NET News in Nebraska.

DICOM metadata offers more accurate study information, according to a Jan. 8 study published in the Journal of Digital Imaging. This may ultimately help increase the efficiency of MRI exams while reducing their associated costs.